USD 5.21
(-6.46%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 13.78 Million USD | -7.06% |
2022 | 14.83 Million USD | 2046.45% |
2021 | 691 Thousand USD | 996.83% |
2020 | 63 Thousand USD | -43.24% |
2019 | 111 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 13.5 Million USD | -2.05% |
2024 Q2 | 13.19 Million USD | -100.0% |
2023 Q2 | 14.32 Million USD | -1.8% |
2023 Q4 | 13.78 Million USD | -1.96% |
2023 Q1 | 14.59 Million USD | -1.62% |
2023 FY | 13.78 Million USD | -7.06% |
2023 Q3 | 14.06 Million USD | -1.88% |
2022 Q2 | 15.68 Million USD | -2.3% |
2022 FY | 14.83 Million USD | 2046.45% |
2022 Q4 | 14.83 Million USD | -3.16% |
2022 Q1 | 16.05 Million USD | 2223.88% |
2022 Q3 | 15.31 Million USD | -2.37% |
2021 FY | 691 Thousand USD | 996.83% |
2021 Q2 | 998 Thousand USD | -13.59% |
2021 Q3 | 864 Thousand USD | -13.43% |
2021 Q1 | 1.15 Million USD | 1733.33% |
2021 Q4 | 691 Thousand USD | -20.02% |
2020 FY | 63 Thousand USD | -43.24% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | 63 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 111 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 99.899% |
Allurion Technologies Inc. | 2.3 Million USD | -497.788% |
Artivion, Inc. | 305.53 Million USD | 95.488% |
Avanos Medical, Inc. | 159.4 Million USD | 91.352% |
Butterfly Network, Inc. | 22.83 Million USD | 39.632% |
Butterfly Network, Inc. | 22.83 Million USD | 39.632% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 98.841% |
Boston Scientific Corporation | 8.96 Billion USD | 99.846% |
CONMED Corporation | 971.48 Million USD | 98.581% |
Edwards Lifesciences Corporation | 670 Million USD | 97.943% |
Paragon 28, Inc. | 109.79 Million USD | 87.445% |
Glaukos Corporation | 383.73 Million USD | 96.408% |
Globus Medical, Inc. | 417.4 Million USD | 96.697% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 44.518% |
Integer Holdings Corporation | 959.92 Million USD | 98.564% |
Medtronic plc | 23.87 Billion USD | 99.942% |
Myomo, Inc. | 115.16 Thousand USD | -11870.302% |
Nevro Corp. | 211.47 Million USD | 93.481% |
Owlet, Inc. | 22 Thousand USD | -62559.091% |
Penumbra, Inc. | 220.9 Million USD | 93.76% |
Smith & Nephew plc | 2.17 Billion USD | 99.366% |
Sonendo, Inc. | 14.03 Million USD | 1.781% |
STERIS plc | 3.12 Billion USD | 99.558% |
Stryker Corporation | 10.9 Billion USD | 99.874% |
Vapotherm, Inc. | 109.97 Million USD | 87.466% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 99.717% |